The second wave of coronavirus has brought some jitters in the domestic stock markets and it again can be a good opportunity for smart investors to go
Ajanta Pharma is gearing up for the next leap driven by improving operating leverage and concluding capex
The brokerage house sees Tata Consumer replacing GAIL in the upcoming semi-annual Nifty50 reshuffle on March 29